Key result
J waves linked to ~195% greater risk of appropriate ICD therapy for VT/VF in NICM.
Why the study?
Does the presence of J waves predict the occurrence of appropriate device therapy for sustained VT/VF in patients with nonischemic cardiomyopathy?
Cohort (n=109)
Does the presence of J waves predict the occurrence of appropriate device therapy for sustained VT/VF in patients with nonischemic cardiomyopathy?
The presence of J waves on a 12-lead ECG is an independent predictor of life-threatening ventricular tachyarrhythmias requiring appropriate ICD therapy in patients with nonischemic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
J waves may identify higher-risk nonischemic cardiomyopathy patients for closer monitoring; leaves open prospective validation before guiding ICD decisions.
INTRODUCTION: Recent studies showed that J waves were associated with higher incidence of ventricular tachyarrhythmia (VT/VF) in patients with idiopathic ventricular fibrillation (VF) and myocardial infarction. We sought to assess the association between J waves and VT/VF in patients with nonischemic cardiomyopathy (NICM). METHODS AND RESULTS: We retrospectively enrolled 109 patients (79 men; mean age, 60 ± 15 years) with NICM who underwent implantable cardioverter defibrillator (ICD) implantation. The primary endpoint of this study was the occurrence of appropriate device therapy due to sustained VT/VF. The J wave was electrocardiographically defined as an elevation of the terminal portion of the QRS complex of >0.1 mV in at least 2 contiguous inferior or lateral leads. Among the 109 patients, 37 (34%) experienced an episode of appropriate device therapy during a median follow-up period of 25.9 (IQR 11.5-54.3) months. Kaplan-Meier curves showed that the presence of J waves on the 12-lead ECG obtained before device implantation was associated with an increased occurrence of appropriate device therapy (P < 0.001). Multivariate Cox proportional regression analysis revealed that the presence of J waves (HR 2.95; 95% CI 1.31-6.64; P = 0.009) was an independent predictor for the occurrence of appropriate device therapy. In the subgroup analysis of the patients with dilated or hypertrophic cardiomyopathy, J wave tended to increase the occurrence of appropriate device therapy (P = 0.056 and P = 0.092, respectively). CONCLUSIONS: The presence of J waves was an independent predictor for the occurrence of appropriate device therapy in patients with NICM who underwent ICD implantation.
No takes yet. Share an insight, caveat, or question.
Naruse et al. (2016) conducted a cohort in Nonischemic cardiomyopathy (n=109). Presence of J waves vs. Absence of J waves was evaluated on Occurrence of appropriate device therapy due to sustained VT/VF (HR 2.95, 95% CI 1.31-6.64, p=0.009). The presence of J waves was an independent predictor for appropriate ICD therapy due to sustained VT/VF in patients with nonischemic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: